Literature DB >> 18095346

Evaluation of evidence for infection as a mode of action for induction of rat lymphoma.

Jane C Caldwell1, Jennifer Jinot, Danielle DeVoney, Jeff S Gift.   

Abstract

The European Food Safety Authority (EFSA) released a 2006 report questioning the relationship of aspartame exposure with increased incidence of lymphomas/leukemias in a European Ramazzini Foundation (ERF) rat study. The EFSA report suggested that the lymphoma/leukemia findings were most likely explained by infection in the rat colony. The ERF has also conducted the only available long-term oral study of methyl tertiary-butyl ether (MTBE). Thus, using the EFSA report as support, some have now raised questions about the human relevance of MTBE-associated hemolymphoreticular tumors reported by the ERF in female rats as well as whether their incidence was elevated above background levels. In this report, we discuss the hypothesized mode of action (MOA) of infection-induced lymphoma and its relevance to MTBE-associated lymphomas. We address the relationship of rat strain and study duration to lymphoma susceptibility and review evidence of low background rates of this tumor in control animals at the ERF, similar survival rates for female rats at the ERF and National Toxicology Program (NTP), and chemical- and gender-specificity of tumor induction for this type of tumor in studies at the ERF. We find that the background incidence of hemolymphoreticular tumors in female rats in the MTBE study is consistent with contemporaneous studies at the ERF and that there is an exposure-related effect, which is unlikely to be due to infections. We examine more recent tumor classification schemes for lymphomas, which support the combination of lymphoblastic leukemias and lymphomas reported by Belpoggi et al. ([1995] Toxicol Ind Health 11:119-149; [1998] Eur J Oncol 3:201-206). Published 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095346     DOI: 10.1002/em.20356

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  3 in total

Review 1.  Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini Institute.

Authors:  Jeffrey S Gift; Jane C Caldwell; Jennifer Jinot; Marina V Evans; Ila Cote; John J Vandenberg
Journal:  Environ Health Perspect       Date:  2013-09-17       Impact factor: 9.031

2.  EFSA's toxicological assessment of aspartame: was it even-handedly trying to identify possible unreliable positives and unreliable negatives?

Authors:  Erik Paul Millstone; Elisabeth Dawson
Journal:  Arch Public Health       Date:  2019-07-15

3.  Authors' response to Ashley Roberts' letter to the editor on aspartame and cancer.

Authors:  Philip J Landrigan; Kurt Straif
Journal:  Environ Health       Date:  2021-09-21       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.